STAT-Dx (STAT-Diagnostica & Innovation), a company that specialises in designing and marketing advanced point-of-care diagnostic systems and a CataloniaBio member, has just received a €20-million loan from the European Investment Bank (EIB) under the InnovFin programme. The company will put this capital towards co-funding a three-year project to develop a device to identify a wide range of infectious pathogens that cause diseases like meningitis or gastrointestinal and respiratory infections, among others. The company is based at the Barcelona Science Park.

STAT-Dx recently won the 2017 Biosucces of the Year Award, with Mosaic Biomedicals, which CataloniaBio grants to the best milestones reached each year. 

More information is available on the EIB website.

Photo: From left to right, Ambroise Fayolle, vice-president of the EIB, and Jordi Carrera, CEO of STAT-Dx - © STAT-Dx